首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.
【2h】

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

机译:如单克隆抗体所揭示对抗药性肿瘤细胞特异的170至180 kDa糖蛋白的功能作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An overexpression of the plasma membrane glycoprotein of relative molecular size 170-180 kDa is consistently found in different multidrug-resistant human and animal cell lines, although the functional role of the protein in multidrug resistance is not known. Two monoclonal antibodies that interfere with biochemical functions were generated against the human myelogenous leukemia K-562 cells resistant to adriamycin (K-562/ADM). These antibodies, designated MRK16 and MRK17, are specifically reactive to K-562/ADM and a human ovarian cancer cell line resistant to adriamycin (2780AD). MRK16 modulated vincristine and actinomycin D transport in the resistant cells, while MRK17 specifically inhibited the growth of the resistant cells. Both antibodies recognized the 170- to 180-kDa glycoprotein. These data indicate that the 170- to 180-kDa glycoprotein is involved, directly or indirectly, in the drug transport mechanisms and the proliferation of multidrug-resistant tumor cell lines.
机译:在不同的耐多药的人和动物细胞系中始终发现相对分子大小为170-180 kDa的质膜糖蛋白的过表达,尽管该蛋白在耐多药性中的功能作用尚不清楚。针对人对阿霉素(K-562 / ADM)的骨髓性白血病K-562细胞产生了两种干扰生化功能的单克隆抗体。这些称为MRK16和MRK17的抗体对K-562 / ADM和对阿霉素(2780AD)有抗性的人卵巢癌细胞系具有特异性反应。 MRK16调节了耐药细胞中长春新碱和放线菌素D的转运,而MRK17特异性抑制了耐药细胞的生长。两种抗体都识别170-180kDa的糖蛋白。这些数据表明170-180kDa的糖蛋白直接或间接地参与了药物转运机制和多药耐药肿瘤细胞系的增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号